Improving the health and well-being of patients affected by Alzheimer’s disease

 

 

Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical stage pharmaceutical company focused on improving the health and well-being of patients affected by Alzheimer’s disease and bringing these therapies to market joins eHealth Radio and the Alzheimer’s Information and Health News Channels.

Listen to interview with host Eric Michaels and guests Ram Mukunda and Claudia Grimaldi discuss the following:

1. Many people are aware of the symptoms of Alzheimer's including dementia, but many are unaware of that agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease. Can you explain why?
2. How does this condition affect those caring for a patient affected by Alzheimer's?
3. How does your investigational drug IGC-AD1 work to help these patients?
4. What are the next steps in bringing this drug to market?
5. What other therapies is IGC Pharma working on in Alzheimer’s?

Ram Mukunda is both the founder and Chief Executive Officer of IGC Pharma. Prior to forming IGC Pharma, he was the President, Chief Executive Officer & Director at India Globalization Capital, Inc., Chairman, President & Chief Executive Officer for Techni Bharathi Pvt Ltd. (a subsidiary of India Globalization Capital, Inc.).

Ram Mukunda previously occupied the position of Council Member at Jamaica Dairy Development Board, Chairman & Chief Executive Officer of Startec Global Communications Corp., Council Member at Harvard Kennedy School of Government and Council Member at Belfer Center for Science & International Affairs.

Ram Mukunda received an undergraduate degree and a graduate degree from the University of Maryland.

Claudia Grimaldi has been with IGC for almost 12 years with increasing responsibilities including managing SEC and NYSE filings, regulatory compliance, and disclosures. She is currently Vice President, Principal Finance Officer, and Chief Compliance Officer. She is also the Managing Director of Hamsa Biochem SAS, our subsidiary in Colombia, as well as a director of our subsidiary in India.

Ms. Grimaldi graduated with a BA in Psychology with high honors from Javeriana University, a top three university in Colombia, and an MBA with high honors from Meredith College in North Carolina. She has completed Executive Education courses on SEC compliance, finance from UVA, and corporate governance from the Columbia Business School.

Website: https://www.igcpharma.com 

People also listened to this: Improving skin health is a journey